The global cardiac marker testing market is projected to grow from USD 5.54 billion in 2026 to USD 9.06 billion by 2031, registering a CAGR of 10.3% during the forecast period. The market was valued at USD 5.07 billion in 2025. The growth of the cardiac marker testing market is primarily driven by the rising incidence of cardiovascular diseases, increasing hospital admissions, and the growing emphasis on early diagnosis and effective risk-factor management.

Top Companies in the Cardiac Marker Testing Market

The competitive landscape of the cardiac marker testing market comprises established diagnostics companies, medical technology companies, reagent manufacturers, and specialized point-of-care testing providers. Key players are focusing on product development, technological innovation, strategic collaborations, geographic expansion, and strengthening their diagnostic portfolios.

1. F. Hoffmann-La Roche AG

F. Hoffmann-La Roche AG is a major player in the global diagnostics industry, with a strong presence in laboratory diagnostics and biomarker testing. The company’s diagnostic portfolio supports automated laboratory workflows and high-throughput testing. Roche’s focus on assay development, automation, and laboratory connectivity strengthens its position in cardiac marker testing and related clinical diagnostics.

2. Abbott Laboratories

Abbott Laboratories has a strong presence in cardiovascular diagnostics and point-of-care testing. The company offers diagnostic solutions designed to support rapid testing across hospitals, laboratories, and decentralized healthcare environments. Its emphasis on portability, automation, and connectivity supports the growing demand for timely cardiac biomarker assessment.

3. Danaher Corporation

Danaher Corporation maintains a significant position in the diagnostics market through its portfolio of operating companies and diagnostic technologies. The company’s focus on automation, laboratory efficiency, digital connectivity, and advanced testing platforms positions it to capitalize on the growing demand for cardiac marker testing.

4. Siemens Healthineers AG

Siemens Healthineers AG provides laboratory diagnostics and healthcare technologies supporting cardiovascular disease diagnosis and monitoring. Its diagnostic solutions emphasize automation, analytical performance, and workflow integration. Continued investment in digital diagnostics and laboratory technologies is expected to strengthen its competitive position.

5. Thermo Fisher Scientific

Thermo Fisher Scientific offers a broad range of analytical and diagnostic technologies used across clinical laboratories and research environments. Its capabilities in immunoassays, reagents, analytical instruments, and laboratory workflow solutions support applications involving cardiac biomarkers and clinical testing.

6. Bio-Rad Laboratories

Bio-Rad Laboratories is a recognized provider of diagnostic products, reagents, quality-control solutions, and laboratory technologies. The company’s focus on analytical reliability and quality assurance supports laboratories seeking consistent performance in clinical diagnostic testing.

7. bioMérieux SA

bioMérieux SA specializes in in vitro diagnostics and provides solutions for clinical laboratories and healthcare institutions. Its expertise in diagnostic testing and decentralized healthcare applications provides opportunities to address the increasing need for rapid and reliable biomarker testing.

8. Becton, Dickinson and Company

Becton, Dickinson and Company (BD) has a broad portfolio spanning diagnostic systems, laboratory technologies, and healthcare solutions. The company’s focus on laboratory workflow optimization and diagnostic efficiency positions it to benefit from the increasing demand for integrated testing solutions.

9. DiaSorin S.p.A.

DiaSorin S.p.A. is a prominent diagnostics company with expertise in immunodiagnostics and molecular diagnostics. Its focus on specialized immunoassays and laboratory testing technologies supports applications requiring sensitive and reliable biomarker detection.

10. Revvity

Revvity develops technologies and solutions spanning diagnostics, life sciences, and laboratory applications. Its capabilities in immunodiagnostic and analytical technologies provide opportunities to address evolving requirements for biomarker testing and disease monitoring.

11. Tosoh Corporation

Tosoh Corporation offers diagnostic analyzers, reagents, and laboratory testing solutions. Its expertise in automated diagnostic systems and immunoassay technologies supports clinical laboratories seeking efficient and reliable testing workflows.

12. Quidel Corporation

Quidel Corporation focuses on diagnostic testing technologies, including rapid and point-of-care diagnostic solutions. The company’s capabilities in decentralized testing support the broader industry trend toward faster diagnostic decision-making outside traditional central laboratories.

13. LSI Medience Corporation

LSI Medience Corporation, part of PHC Holdings Corporation, provides clinical laboratory and diagnostic services and technologies. Its expertise in laboratory testing and healthcare diagnostics supports the growing demand for reliable biomarker analysis.

14. Randox Laboratories

Randox Laboratories develops clinical diagnostic products, analyzers, reagents, and quality-control solutions. The company emphasizes diagnostic accuracy and laboratory efficiency, supporting healthcare providers and laboratories in a wide range of clinical applications.

15. Guangzhou Wondfo Biotech Co., Ltd.

Guangzhou Wondfo Biotech Co., Ltd. specializes in diagnostic products and point-of-care testing technologies. Its focus on rapid diagnostics and decentralized testing positions the company to benefit from increasing demand for accessible cardiac marker testing.

16. Boditech Med Inc.

Boditech Med Inc. focuses on point-of-care diagnostic systems and immunoassay technologies. Its portable testing solutions can support rapid biomarker analysis in healthcare settings where immediate diagnostic information is important.

17. BTNX Inc.

BTNX Inc. develops rapid diagnostic and point-of-care testing products. The company’s focus on accessible and easy-to-use diagnostic technologies supports the broader movement toward decentralized testing and rapid clinical decision-making.

18. Response Biomedical

Response Biomedical specializes in point-of-care diagnostic testing technologies. Its focus on rapid diagnostic testing addresses the need for timely biomarker results in emergency and acute-care environments.

19. Alfa Scientific Designs, Inc.

Alfa Scientific Designs, Inc. develops rapid diagnostic testing products and immunoassay-based technologies. Its diagnostic portfolio supports decentralized testing environments and contributes to the growing availability of rapid diagnostic solutions.

20. CTK Biotech

CTK Biotech develops and manufactures in vitro diagnostic products, including rapid diagnostic tests and immunoassay technologies. The company serves healthcare markets with a focus on accessible diagnostic solutions.

21. Creative Diagnostics

Creative Diagnostics provides diagnostic reagents, assay development services, and research-related diagnostic technologies. Its capabilities in biomarker analysis and assay development support applications across clinical diagnostics and life sciences research.

22. LifeSign LLC

LifeSign LLC focuses on rapid diagnostic technologies designed to provide timely testing results. Its emphasis on point-of-care and rapid testing aligns with the growing demand for decentralized diagnostic solutions.

23. DiaSys Diagnostic Systems GmbH

DiaSys Diagnostic Systems GmbH develops clinical chemistry and diagnostic solutions for laboratories. Its portfolio supports routine and specialized laboratory testing, contributing to the broader clinical diagnostics ecosystem.

24. Atlas Medical GmbH

Atlas Medical GmbH provides diagnostic and laboratory solutions for healthcare applications. Its products contribute to the expanding availability of clinical testing technologies across healthcare settings.

25. Getein Biotech Inc.

Getein Biotech Inc. focuses on in vitro diagnostics and point-of-care testing solutions. Its technologies support rapid biomarker analysis and decentralized diagnostics, areas expected to gain importance as healthcare providers seek faster testing and clinical decision-making.